newsfilter
← Latest News
ACCESS Newswire·

IGC Pharma Launches Strategic National Media Partnership with New to The Street to Expand Investor Awareness

  • IGC Pharma (NYSE: IGC) announced a strategic 12-part national media partnership with New to The Street on March 30, 2026.
  • The collaboration aims to enhance visibility among institutional & retail investors through a multi-channel strategy including televised interviews, TV commercials, digital amplification, & outdoor placements.
  • IGC Pharma will be featured on sponsored programming on Fox Business & Bloomberg Television.
  • Digital amplification will reach over 4.45 million YouTube subscribers, complemented by billboard placements in Times Square & the NYC Financial District.
  • New to The Street integrates national TV exposure with digital, social, & outdoor media distribution alongside curated events for accredited investors.
  • IGC Pharma is a clinical-stage biotechnology company using AI to develop treatments for Alzheimer's disease & metabolic disorders.
  • The company's lead asset IGC-AD1 is currently in a Phase 2 CALMA trial for agitation in Alzheimer's dementia.
  • The pipeline includes TGR-63 targeting amyloid plaques, plus early-stage programs focused on neurodegeneration, tau proteins, & metabolic dysfunctions.